LOXL2 and central nervous system cancer: In this study, we integrated multi-dimensional bioinformatics techniques, including transcriptome data analysis, clinical prognostic parameter modeling and immune microenvironment analysis, to systematically elucidate the molecular mechanism of LOXL2 in glioma development and its clinical translational potential.